BioCord | Células Madre

What BioCord | Células Madre does

BioCord is a privately held umbilical cord blood and tissue stem cell bank operating in Spain through its Madrid office and under Swiss-domiciled parent BIOCORD AG (Zug). Founded in 2004 and operated via its banking subsidiary BebéVida, the company offers a three-tier service portfolio built around cryopreservation at approximately -190°C with 30-year conservation guarantees: BioCord First (cord blood hematopoietic stem cells), BioCord Advanced (adds cord tissue mesenchymal stem cells), and BioCord Proficiency (exclusive to BioCord, adds mesenchymal stem cell isolation and quality/vitality certification). Service delivery is anchored in a single in-house facility that receives, processes, and stores samples, eliminating secondary transport risk and aligning with Decree Law July/2014 requirements for cord blood handling. Samples are collected via EU-certified kits with embedded temperature dataloggers and validated by Softbox Systems under pressure, impact, and immersion testing.

The business model is fundamentally subscription/contract-based: families pay for a multi-decade conservation package that includes the extraction kit, personalized shipping, in-house processing, 30-year storage, semi-annual quality controls, medical advisory in case of transplant, and financial assistance for transplant costs. BioCord operates a hybrid GTM combining direct-to-consumer sales (website, call center, WhatsApp, in-person advisors) with B2B2C distribution through 14+ Spanish health insurers (ASISA, ADESLAS, AXA, CASER, CIGNA, DKV, SALUS, IMQ, FIATC, HNA, OCCIDENT, MGC MUTUA, MAPFRE, SANITAS, MUTUACAT), supplemented by event-driven acquisition at baby fairs and clinical congresses. Pricing is not publicly disclosed; special conditions exist for uninsured families and twin births.

BioCord is governed under the BIOCORD AG corporate structure (Switzerland-domiciled, Madrid-based operational branch) and has run continuously since 2004. Its technology and clinical position is anchored by references to FACT NetCord and AABB quality standards, a Scientific Director (Dr. Luis Madero López) with Forbes recognition, and a small marketing leadership (Macarena Campos, Marketing Director). The company currently does not publicize revenue, headcount, or funding rounds, and there is no evidence of geographic expansion beyond the Iberian Peninsula or of AI/ML capability within its product stack.

Name

BioCord | Células Madre

Legal name

BIOCORD AG

Website

https://bio-cord.es

Company type

Private

Founded year

2004

Operating status

Operating

Headcount range

11–50 employees

Short description

BioCord is a privately held Spanish stem cell bank that cryopreserves newborns' umbilical cord blood and tissue at approximately -190°C, offering tiered 30-year conservation contracts to families and distributing through 14+ Spanish health insurers.

Ownership category

akta.pro rank

Product category

Stem Cell Banking Services

NAICS

Blood and Organ Banks (621991)

SIC

Biological Products, (No Disgnostic Substances) (2836), Services-Medical Laboratories (8071)

akta.pro primary industry

Cell & Tissue Banking (biobanking, cord blood/tissue) (HLAAAGAE)

Keywords

• Stem cell banking
• Cord blood conservation
• Umbilical cord tissue storage
• Cryopreservation services
• Biological insurance

Headquarters

HQ city

Madrid

HQ country

Spain

HQ region

Europe

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Operations, Personnel, Infrastructure, Marketing or Sales, Technology or R&D, Supply Chain

Revenue model

1. Stem Cell Conservation Services: Three-tier service model: BioCord First (umbilical cord blood conservation), BioCord Advanced (adds tissue conservation), and BioCord Proficiency (adds mesenchymal stem cell isolation and certification). Services include 30-year conservation, extraction kit, personalized shipping, processing, and medical advice in case of transplant.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels5 records

Core offering

BioCord is a private stem cell bank that conserves umbilical cord blood and tissue stem cells for families expecting babies across three service tiers: BioCord First (cord blood hematopoietic stem cell conservation), BioCord Advanced (adds cord tissue mesenchymal stem cell conservation), and BioCord Proficiency (adds mesenchymal stem cell isolation and certification). All services include a temperature-controlled extraction kit, personalized shipping, in-house processing at approximately -190°C, a 30-year conservation guarantee, medical advisory, and financial assistance in case of transplant.

Product overview

BioCord is a private cord blood bank offering a tiered service portfolio for the preservation of umbilical cord blood and tissue stem cells. The core offering consists of three service levels: BioCord First (conservation of hematopoietic stem cells from cord blood with isolation and certification), BioCord Advanced (adds conservation of mesenchymal stem cells from cord tissue), and BioCord Proficiency (the most comprehensive tier adding tissue-derived mesenchymal stem cell isolation and certification). All services include extraction kit with temperature control, personalized shipping, 30-year conservation guarantee, medical advisory in case of transplant, and financial assistance for transplant costs.

Differentiator

Problem solved

Functional benefit

Brands

• BebéVida: The stem cell bank operated by BioCord for conservation of umbilical cord blood and tissue samples.
• BioCord First
• BioCord Advanced
• BioCord Proficiency

Products and services

• BioCord First Entry-level service for conservation of umbilical cord blood (hematopoietic stem cells) with isolation and certification of quality and cellular vitality. Includes extraction kit with temperature control, personalized shipping, processing, 30-year conservation guarantee, medical advisory in case of transplant, and financial assistance for transplant costs. Aimed at expectant families seeking biological insurance for their newborn.
• BioCord Advanced Intermediate service tier that includes all BioCord First features plus conservation of umbilical cord tissue (mesenchymal stem cells). Includes temperature-controlled extraction kit, personalized shipping, processing, 30-year conservation guarantee, medical advisory, and transplant cost assistance. Aimed at expectant families seeking broader stem cell preservation.
• BioCord Proficiency Premium service tier available only at BioCord, including all First and Advanced features plus isolation and certification of mesenchymal stem cells from tissue, with quality and vitality documentation. Includes temperature-controlled extraction kit, personalized shipping, processing, 30-year conservation guarantee, medical advisory, and financial assistance for transplant costs. Aimed at families seeking the most comprehensive stem cell preservation option.

Quantifiable outcome

• Processing and conservation in single destination avoids temperature fluctuations from secondary transport that could destroy samples

Named customers14 records

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration2 records

Feature4 records

Partnerships

Four partnerships are on record, tiered minor and core.

• Fundación Apadrina un ÁrbolminorStrategic or Co-development PartnerThrough Proyecto Vidas, BioCord sponsors tree planting for each baby whose stem cells are conserved, helping regenerate the Guadalajara area devastated by fire in 2005. Also aims to raise awareness and educate future generations about natural resources.
• Fundación Prójimo PróximominorStrategic or Co-development PartnerBioCord sponsors sports events (pádel and golf tournaments) organized by this foundation that supports people with physical, psychological, or sensory disabilities. All funds raised go directly to the foundation's work.
• FACT NetCordcoreOthersAccreditation organization for cord blood banks and cellular therapy programs. BioCord references this body as the standard for quality certification.
• AABB (Association for the Advancement of Blood and Biotherapies)coreOthersInternational organization promoting quality and safety in blood and biotherapies. BioCord references this body as a key standard for the industry.

Scale indicators3 records

Recent moves6 records

Expansion highlights4 records

Broad incumbents

• Cryo-Save (Esperite): European-scale private stem cell bank with broader portfolio (cord blood, cord tissue, adipose-derived MSCs, dental pulp). Larger, more diversified incumbent in BioCord's category.
• AMAG Pharmaceuticals (Cord Blood Registry / CBR): Largest US cord blood bank, historically the category leader. Same core product family but at significantly larger scale and with broader geographic reach than BioCord.

Direct peers

• Cells4Life: UK private cord blood bank offering multi-tier storage including tissue and mesenchymal cell processing. Closest UK analog to BioCord's First/Advanced/Proficiency tiering.
• Vita 34: Germany-based stem cell bank offering cord blood and tissue storage across Europe. Comparable business model (direct + insurance/HCP partnerships), with international footprint BioCord lacks.
• Future Health Biobank: UK/Switzerland-based stem cell bank with European operations and ISO/FACT-accredited processing. Comparable service model with cord blood and tissue storage plus MSC isolation, similar tiering approach to BioCord.
• Smart Cells: UK private umbilical cord blood stem cell bank. Operates a comparable direct-to-consumer + insurer/HCP model in a closely adjacent European geography.
• Sevibe Cells: Spanish and European cord blood and tissue bank serving families and insurers across Iberia. Competes head-to-head with BioCord for the same expectant parent and insurance partner relationships.
• Crio-Cord: Spanish private umbilical cord blood bank offering similar three-tier storage services to Spanish families and through insurance partnerships. Directly comparable in geography, product, and customer profile to BioCord.

Emerging players

• Auxocell Laboratories: US-based cord tissue and MSC processing specialist. Narrower product line than BioCord but intersects on the mesenchymal stem cell processing capability that defines BioCord's Proficiency tier.

Regional players

• Magenta Bio: Italian cord blood and tissue stem cell bank offering similar family-focused storage services. Comparable product offering but operates primarily in Italy rather than Iberia.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/biocord
• YouTubeyoutube.com/channel/UC_3f1IV6n85uqko9r46msVg
• Facebookfacebook.com/CelulasMadreBioCord
• LinkedInlinkedin.com/company/bio-cord
• Instagraminstagram.com/biocord

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about BioCord | Células Madre